SPCX

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+1.25%

Status

scored

Maintain core SPCX exposure at a hard-capped 5-6% portfolio weight (down from the 8-10% Research Manager target) with a pre-stop damage protocol that trims 25% on closes below $150 and an additional 25% below $146 before the $143 hard stop triggers a full exit. For fresh capital, wait for the bullish re-engagement trigger (close above $170.19 on >100M volume with MACD re-acceleration and RSI>60) or the bearish capitulation trigger (flush to $143-145 on >100M with RSI<40), rather than initiating at the current $160 level.

Outcome

✗

Return

-4.19%

Status

scored

Maintain HOLD rating at $167.60 with a 25% trim triggered at $172 and additional 10% trim on confirmed close above $185 with volume >100M, totaling 35% trim across full zone execution (residual 65%). New capital should await $153-$159 pullback with RSI<50 or breakout above $185. Hard stop at $144.75 (200 SMA). Mandatory reassessment at Q3 2026 earnings and Starship Flight 15 outcome, with price target of $180.

Outcome

✓

Return

-2.51%

Status

scored

Maintain HOLD at $171.92 with no new capital deployment as RSI at 69.36 and price above the upper Bollinger Band ($167.12) make current levels unattractive for adding. Re-engage on either a pullback to $158-160 with RSI reset to 55-60 for 1.5x sizing, or a daily close above $175 with volume >100M for 1x sizing. Primary stop sits at $158 with damage escalation at $150, $141, and $130 levels.

Outcome

–

Return

+0.49%

Status

scored

Initiate overweight at $163 with a measured 50-65% initial position given the Q2 2026 inflection ($4.1B EBITDA swing, 600bps gross margin expansion, 92% YoY revenue growth) as the dominant signal, though 89x forward P/E and an unconfirmed 3-session breakout warrant discipline. Scale to 80-100% on confirmed close above $172.47 with volume or successful $154 retest with close back above $163; hard stop at $144 (200 SMA, 1.5x ATR). Reassess at Q3 2026 earnings: revenue ≥$7.5B and gross margin ≥53% confirms upgrade to Buy; revenue miss >10% or gross margin <50% triggers exit.

Outcome

✗

Return

+7.63%

Status

scored

Sell 50% of SPCX position in tranches within $155-160 zone (30% at $155-157, 20% at $158-160) to capture the 7% breakout on 119M volume, with a $143.77 stop at the 200 SMA; retain 50% residual to participate asymmetrically in operational catalysts (Starship milestones, Q3 2026 earnings) while capping downside given 91x sales valuation and deteriorating 5x FCF in a no-cut macro regime.

Outcome

✗

Return

+7.35%

Status

scored

Trim 60% of SPCX long exposure at market near $148, retaining 40% residual for asymmetric participation in operational inflection, with widened stop at $138 (50 SMA, ~1.5x ATR buffer). The 60% trim synthesizes four binding SPCX reflections (9/22, 9/25, 9/28, 9/30) and the 9/30 NFLX high-beta cross-ticker lesson, sitting at the intersection of Trader/Aggressive (50%) and Neutral (60-65%) positions while avoiding the 9/28 over-trim failure mode. Re-entry triggers are clean reclaim above $157.48 on volume >150M shares or capitulation flush below $130 with reclaim of $137 within 3 sessions.

Outcome

✓

Return

-1.85%

Status

scored

Maintain SPCX core position at $150.86 with a HOLD rating based on balanced analyst debate between structural bull case (92% revenue growth, $100B cash, Starship orbit, $54B AI ARR) and tactical bear case (86x forward P/E, FCF deteriorating 85% QoQ, 50 SMA below 200 SMA); tighten stops to $147 and take 25-33% partial profits into any $158-$162 extension. Key catalyst milestones requiring reassessment within 30-45 days include Starship Flight 15 outcome (48hrs post-launch), Q3 2026 earnings (sequential revenue >$6B and sustained OCF positive for upgrade path), and Polymarket Starship probability above 65%; if $142-$156 range doesn't resolve by mid-November, the position must be reassessed.

Outcome

✓

Return

+1.09%

Status

scored

Maintain SPCX at Hold with no additions above $148 until mechanical confirmation triggers fire or Q3 earnings validate the operational inflection; the structural bull case is sound (87% sequential op loss compression, $93.5B cash fortress, Polymarket Starship probability at 62%) but leading technicals are deteriorating (MACD bearish cross, RSI rolling at 62) and the binary Q3 catalyst ahead makes blind adds asymmetric risk. Stop at $143.41 (200 SMA), with path to Overweight on MACD histogram turn + close above $148.96 + volume >79.7M shares, or larger add on pullback to $136.94 (50 SMA) or breakout above $156.56 with volume.

Outcome

✗

Return

+2.59%

Status

scored

Trim 70-80% of SPCX long exposure at $145-147 within 1-2 sessions, retaining 20-30% as a tactical pilot. The 9/25 binding reflection forces a binary choice: full exit with defined re-entry triggers or accept that residual above ~20% recreates the drawdown drag that produced three consecutive negative-alpha outcomes (9/23 -0.1%, 9/24 -0.1%, 9/25 -1.4%). Hard stop on residual at $141.50.

Outcome

✓

Return

-2.16%

Status

scored

Underweight SPCX with a 30% trim of long exposure front-loaded at $148-150, retaining 70% residual for post-Flight 14 reassessment. The underweight rating reflects unanimous directional conviction on the downside given cash burn acceleration (5x escalation from -$3.2B to -$16.8B over four quarters), $85.7B equity raise dilution at a 34% drawdown, hostile macro environment (10Y at 2007 highs, 96% no-cut probability), and technical distribution (three failed breakouts at $154-155). The 30% trim magnitude is calibrated below the 40-60% binding range lower bound, honoring the 9/24 binding reflection to "scale inversely to drawdown magnitude" given the 34% drawdown from $225 to $148 has already absorbed realized volatility, and two consecutive trim failures (9/23: -0.1% alpha, 9/24: -0.1% alpha) at this price zone demonstrated that magnitude overconfidence should be avoided.

Outcome

–

Return

+0.44%

Status

scored

Sell rating with 50-55% trim of SPCX long exposure, front-loaded 30-35% at $148-150 and optional 15-20% additional on extension to $153-155; retain 45-50% residual for post-catalyst reassessment with $141.50 hard stop and three reassessment points: Starship Flight 14 outcome (48hr post-launch), 10-day time-stop, and Q3 2026 earnings.

Outcome

–

Return

-0.22%

Status

scored

Unanimous directional consensus across all three analysts warrants a SELL rating with 75-85% trim of SPCX long exposure executed front-loaded at $148-152 ahead of the September 24 unlock of 328M shares. The 15-25% residual functions as a tactical pilot with a $141.50 stop, requiring either clean post-unlock absorption or capitulation flush plus reclaim for tactical re-engagement, with structural preconditions (macro normalization, valuation normalization, or operational validation) needed for full position rebuild.

Outcome

✓

Return

-4.11%

Status

scored

The portfolio manager settles on Underweight with a 35-40% front-loaded trim to 60-65% of benchmark weight, calibrated above the trader's conservative 25-30% prescription based on binding prior SPCX lessons where upper-bound sizing consistently outperformed. A unanimous $142.87 stop protects the residual position while four re-entry triggers (technical breakout above $170, operational Q3 confirmation with EBITDA ≥$2.5B, pullback to $130-135, and macro/valuation normalization) govern re-engagement; a put hedge is rejected as redundant given the stop mechanism.

Outcome

✗

Return

+1.89%

Status

scored

Trim SPCX long exposure by 55-60% (front-loading 30% immediately and 25-30% on $155 touch), retaining 40-45% for post-Flight 14 reassessment. The Underweight thesis rests on three structural concerns: forced 24.5% share dilution at $130-$140, textbook distribution volume profile (335M vs 81M on up-days), and 87x forward P/E pricing in perfection against Polymarket catalyst disappointment odds (54% odds of <5 Starship launches in 2026). Reassess at Flight 14 (Sept 28), 10-day post-launch, and Q3 2026 earnings.

Outcome

✓

Return

-0.56%

Status

scored

Underweight rating on SPCX with a decisive 40-50% trim of long exposure at current $152 levels, retaining 50-60% strategic core. The recommendation anchors to a hard stop at $134.63 (50 SMA) and tactical escalation trigger at $145, while rejecting both a full Sell (which would destroy asymmetric participation in the Sept 28 Starship Flight 14 catalyst) and an Overweight position (prohibited by current technical deterioration with explicit Bollinger rejection and 73% MACD collapse).

Outcome

✓

Return

-1.36%

Status

scored

Trim 25% of SPCX exposure in two stages (15% front-loaded at $154-156, 10% into $156-160 resistance) while maintaining 60-70% core position with hard stop at $148.61 (10 EMA break). Reassess after September 28 Flight 14 catalyst and Q3 2026 earnings (~4 weeks) based on bear case requiring ~$28B H2 net income against H1's -$4.82B loss and 97% Flight 14 failure probability, balanced against tested institutional floor and auditable Q2 operational inflection (+92% YoY revenue).

Outcome

✓

Return

+2.60%

Status

scored

Adopt the Overweight framework by scaling into 1.5-2.0% of portfolio via three tranches—Tranche 1 (40%) at $150-152, Tranche 2 (30%) at $147.24 (10 EMA pullback), and Tranche 3 (30%) post-Flight 14—with a hard stop at $135 and tactical stop at $140; the 9/15 SPCX Underweight failure (-5.6% alpha) and 9/10 Hold success (+1.2% alpha) mandate constructive-but-disciplined participation rather than bearish over-commitment given the institutional floor's proven resilience and auditable Q2 2026 operational inflection.

Outcome

✗

Return

+5.15%

Status

scored

Override Research Manager's Hold and Trader's Hold with Underweight, trimming 25-30% of SPCX front-loaded at $143-145 rather than waiting for $150+ resistance, with residual stop at $140 on confirmed close below $140 with volume >60M; the decision is driven by at least ten stacking bearish overlays—including 82x forward P/E, bearish MACD cross, session-low close, 200 SMA at risk, Starship Flight 14 within two weeks, 5%+ 10-year yield, $47B lockup overhang, Q3 earnings binary, and Anthropic/IPO supply pressure—implementing binding lessons from the 9/14 SPCX reflection (8+ overlays mandates anchoring magnitude to midpoint/upper bound), AMD 9/11 cross-ticker lesson (clean collar cannot be put on high-beta, catalyst-sensitive name defaults to Underweight), and 9/11 SPCX reflection (bearish catalyst count exceeds 4 independent overlays shifts trim default upward by at least one tier), while the $94B cash fortress, Nvidia $21B/Harvard $2.2B/Alphabet $94B institutional floor, and Q2 audited operational inflection (+92% YoY revenue, +1,140bps gross margin expansion, $4.1B EBITDA swing) bound downside and prevent full Sell.

Outcome

✓

Return

-3.15%

Status

scored

Trim 25% of SPCX exposure at current levels ($147-149) via front-loaded execution, with residual stop confirmed at $142 on >60M volume. The rating defaults to Underweight based on three converging binding lessons: the 9/11 SPCX reflection (nine independent overlays exceed the 4+ threshold requiring magnitude shift upward by one tier), the AMD 9/11 cross-ticker lesson (no clean options hedge available means rating should default to Underweight, not Hold), and the 9/04 SPCX reflection establishing a 15-20% baseline shifted to 25-30% due to overlay density. The price target of $140.0 represents the conservative end calibrated to preserve 75% of benchmark participation while capturing meaningful downside protection ahead of binary catalysts (Q3 2026 earnings, Starship Flight 14, second lockup tranche).

Outcome

✓

Return

-2.02%

Status

scored

Trim 20% of SPCX exposure at current levels ($150-152), front-loading the reduction rather than waiting for resistance at $154-156, with a tightened stop to $140 and meaningful core retention of 1.5-2.0% while reassessing after Starship Flight 14 and lockup tranche resolution.

Outcome

✓

Return

+2.04%

Status

scored

Maintain HOLD with modest positioning as binary catalysts (59M-share lockup now active, Sept 30 FCC vote) create a genuinely balanced risk-reward with no valuation buffer at 98x sales multiple on -38.6% TTM net margin. Do not add exposure ahead of either event; trim 10-15% into $154-160 resistance zone only if 50 SMA has not yet turned up, but hold through breakout if 50 SMA confirms first. Add only on confirmed breakout structure (multi-day close >$154 with MACD expanding AND 50 SMA no longer declining). Mechanical invalidation: daily close <$130 on volume >70M.

Outcome

✗

Return

+0.43%

Status

scored

SPCX warrants an Underweight rating with a 15-20% trim recommendation at current levels ($147-148), front-loaded rather than contingent on resistance retest, based on the binding 9/04 SPCX reflection that explicitly counsels conservative-end sizing at elevated multiples (88x forward P/E). Four near-term headwinds converge to justify reducing exposure: the 50 SMA below 200 SMA confirming recovery rather than uptrend, $47.2B unlock overhang, mathematically certain stop-loss clipping, and capital rotation risk from the mid-October Anthropic IPO. Anchor residual stop at $141.97 (200 SMA) with confirmed-close condition.

Outcome

✓

Return

-3.86%

Status

scored

Trim SPCX by 20% to reduce extended exposure at 96.8x forward P/E while preserving 80% benchmark-relative participation, guided by the binding 9/04 reflection that prescribes conservative-end sizing at high multiples rather than aggressive trimming that has historically destroyed alpha on this name.

Outcome

✗

Return

+3.73%

Status

scored

The decision calls for a 25-35% trim of SPCX exposure, front-loaded at current levels ($147-149) and on any $150-152 retests, given 92x forward P/E, accelerating FCF burn (-$14.1B, +162% YoY), and the Sept. 9 share unlock as a binary catalyst. Hard stops are rejected in favor of options-based hedging or volatility-adjusted sizing (5% residual cap), with re-engagement conditional on a two-confirmation gate: close above the 50 SMA at $135.98 without panic volume AND positive MACD histogram in the $140-142 zone.

Outcome

–

Return

-1.20%

Status

scored

Maintain OVERWEIGHT on SPCX despite the Research Manager's Underweight and Trader's SELL — three binding lessons from prior SPCX reflections (9/02 institutional floor gravity, 9/02 CRM cross-ticker lesson, 8/14 audited operational inflection) argue against trimming into an institutional-grade breakout with confirmed revenue reacceleration (+92% YoY, GM 55.3%). Cap total exposure at 4% portfolio weight with a hard stop at $136 and a pre-committed Starship-resolution plan; add 10-15% on pullback to $141-143 or confirmed breakout above $150 with MACD >+0.92.

Outcome

✗

Return

+6.42%

Status

scored

SPCX is rated UNDERWEIGHT with a recommended 15-20% trim, retaining 80-85% of benchmark weight. The recommendation is based on the binding 9/01/2026 reflection noting that a smaller tactical trim is warranted given coiled technicals at the 200 SMA ($141.43) and unresolved MACD compression, rather than pure Hold which has produced alpha destruction on identical setups, or aggressive trim which replicated the 8/25/8/26 failure pattern. Hard stop set at $133.20 closing basis with $141.43 re-engagement trigger on confirmed volume breakout.

Outcome

✓

Return

-1.07%

Status

scored

Maintain SPCX at Hold rating per Research Manager and Trader consensus—the chart shows coiled lower highs ($149.60 → $149.80 → $145.23) with lowest volume in 30 sessions and razor-thin 200 SMA test, while audited Q2 inflection (revenue +92%, GM +1,140bps, EBITDA +$2.96B) and $93.5B cash fortress with institutional anchors (Nvidia $21B 13F, MS $300 PT) prevent full Sell; adopt Neutral analyst's three-tier phased framework to deploy on confirmed momentum, breakout, or pullback support without rating change.

Outcome

✓

Return

-1.02%

Status

scored

Maintain SPCX at Hold—do not add without a confirmed breakout above $146 on volume >80M with expanding MACD, and do not exit without a breakdown below $130 on volume; hard stop at $128. The fundamental floor is audited (Q2'26 revenue +92% YoY, GM 55.3%, EBITDA +$2.96B, $93.5B-$100B cash) and institutional anchors (NVDA $21B 13F, JPM, MS $300 PT) provide asymmetric protection, but the Aggressive analyst's 12-to-1 R/R and the Neutral analyst's $136 stop tightening are rejected—compressed ATR would guarantee noise-driven exits before binary catalysts play out.

Outcome

✗

Return

+1.55%

Status

scored

SPCX receives an Underweight rating with a recommended 15-25% trim (retaining 75-85% of benchmark weight), scaling sales into $146-148 across 2-3 tranches. The hard stop on residual positions is set at $134.50 (closing basis), while $155.88 represents the exit target for residual longs—not a stop loss. No new longs should be initiated absent a confirmed close above $146 on volume exceeding 70M coupled with Fed pricing softening, or alternatively a flush to $113.

Outcome

–

Return

+0.45%

Status

scored

Underweight SPCX with a 15-25% trim (75-85% benchmark retention), scaled smaller than the Trader's proposed 40-50% reduction per binding 8/25 and 8/26 lessons, honoring the institutional floor while operationalizing trim-before-catalyst discipline ahead of Jackson Hole and September 16 FOMC. Scale sales into the $144-148 zone across 2-3 tranches with a hard stop at $122-125 daily close; no fresh longs until confirmed close above $147 on >100M volume AND favorable macro window, with conditional re-engagement at 95-110% benchmark on price-action confirmation.

Outcome

✗

Return

+0.89%

Status

scored

SPCX maintains UNDERWEIGHT rating with 65-70% benchmark weight allocation, justified by 7-session MACD decay into overhead resistance at the 50 SMA ($139.98) and 87x forward P/E anchored to unaudited estimates. The recommendation trims 15-20% at current levels ($139.50-140.00) and 10-15% on any relief bounce into the $141-143 SMA cluster, with a $132 closing-basis hard stop and $142 re-engagement trigger. The institutional floor (Nvidia $21B, Harvard $2.2B, JPM/MS) and audited 92% YoY revenue growth prevent a full Sell rating.

Outcome

✗

Return

+1.22%

Status

scored

Trim SPCX 40-50% at current $137.95 with phased execution on bounces to $141-143, capping residual at ≤50% of prior allocation and ≤3% of NAV. Stop residual longs at $143 (volatility-adjusted); hard cut if price closes below $130 on volume. Re-engage on confirmed close above $146 on >150M volume, constructive pullback to $115-125 with RSI >40, or post-Jackson Hole stabilization. Rating Underweight justified by 86x forward P/E, bear flag confirmed with three SMA rejections, $85.7B dilution arithmetic, and 86% no-cut odds leaving zero multiple-expansion tailwind.

Outcome

✓

Return

+2.19%

Status

scored

Maintain SPCX at current size with a $128 hard stop and 6-9 month $130 puts as tail hedge, explicitly rejecting both the aggressive analyst's pre-catalyst add and the conservative analyst's collar structure that would cap upside at $155. Do NOT add at $135 due to binary catalyst risk from NVDA earnings (8/26), Jackson Hole (8/28), Starship tests, and remaining lockup tranches. Re-enter size only after post-catalyst confirmation via confirmed close above $146.23 on >100M volume, retest of $108 on declining volume, or Q3 earnings validating the operating leverage thesis.

Outcome

✓

Return

-1.44%

Status

scored

Maintain SPCX exposure without adding at current $134-137 levels. Use the compressed three-tier engagement system: 1.5% on post-lockup validation after 3-5 sessions with no close below $130, 1.5% on breakout above $146.23 with >80M volume and MACD histogram above 3.0, and 5% on pullback to $115-125 with RSI >40. Keep the $130 closing-basis stop unchanged — tightening to $132 would be too tight given ATR of 9.83. Reassess after Starship test, lockup tranche #2, and Q3 earnings.

Outcome

✗

Return

+2.22%

Status

scored

Trim SPCX to 50% of prior position (max 2% of portfolio NAV) by selling 40–50% into rallies at $138–$141.73; do not add at current levels or initiate new longs. Reassess only on a confirmed close above $141.73 with >150M shares; liquidate remainder if SPCX closes below $108 weekly.

Outcome

✓

Return

-4.05%

Status

scored

Trim SPCX 40-50% at current levels ($139.65) and on any relief bounces toward $143-146, capping residual at ≤35% of prior allocation and ≤3% of portfolio NAV. The Underweight rating reflects audited Q2 operational inflection (+92% YoY revenue, 55.3% gross margin, +$2.96B EBITDA, +$2.42B OCF) coinciding with named institutional accumulation that prevents a full Sell, while the 60-90 day binary catalyst cluster (Starship test, lockup digestion, Q3 earnings) precludes passive Hold. Hedge residual with $120/$110 put spreads on 25-30% of remaining position.

Outcome

✓

Return

-2.57%

Status

scored

Maintain HOLD on SPCX at smaller-than-typical sizing (1-2% portfolio cap) with hard $108 closing-basis invalidation and no incremental adds into the 319M-share unlock window or Jackson Hole event. The long-term operational thesis remains intact with Q2 2026 revenue up 92% YoY, gross margin expanding to 55.3%, and institutional validation via Nvidia's $21B 13F disclosure, but near-term risk-reward is roughly symmetric given 7% ATR into concentrated supply, 30Y yield at 19-year highs compressing an 86x forward P/E, and price 36-37% off June highs—warranting reduced exposure until post-unlock stabilization or constructive pullback to $130-135 zone.

Outcome

✓

Return

-1.98%

Status

scored

Underweight rating maintained with a 40-45% phased trim of SPCX exposure across three tranches: 15% at $149-150 resistance retest, 15% on close below $147.50, and 10-15% ahead of the lockup unlock, capping residual at ≤50% of prior allocation with hard stop at $138 closing basis and full exit triggers at $108 with volume >150M and RSI <40. Re-evaluate in 60-90 days after Starship catalyst, lockup tranche #2, and Q3 earnings.

Outcome

✗

Return

+4.45%

Status

scored

Trim SPCX 40-45% via three tranches (15% into relief rally to $144-146 over 3-5 sessions, 10-15% ahead of lockup unlock, 10-15% ahead of Starship catch catalyst), capping residual at ≤50% of prior allocation. Hedge 25-30% of residual with $120-125 put spread for Starship-failure scenario; hard stop at $128 closing, hard exit below $108 on >150M volume with RSI <40.

Outcome

✓

Return

-0.91%

Status

scored

Maintain SPCX at $141.29 with a Hold rating—do not add new capital at the current pivot level, which has been rejected twice at upper Bollinger bands ($146.15, $145.02) with MACD histogram deceleration and fading RSI. Scale in on a pullback to the $130–131 zone (10 EMA confluence) or a confirmed two-session close above $145 on volume >110M, using a hard stop at $123 (1.7 ATR below VWMA) and a 2.5–3% portfolio position size, with mandatory 25–50% pre-event trim ahead of Starship test flights, lockup tranches, or CPI prints.

Outcome

✓

Return

-3.33%

Status

scored

Maintain SPCX at Hold with no directional conviction at current ~$146 level—avoid initiating new positions at $145-155 after the 35% reversal in eight sessions, which statistically tends to mean-revert rather than break out; scale in on pullbacks to the $130-140 zone (layered with 10 EMA at $128.59 and 50 SMA at $141.86 support) or confirmed breakout above $155 with >200M volume sustained 2 sessions; cap position at 1-2% of portfolio given 7.6% ATR and apply mandatory 25-50% pre-event trim 24-48 hours ahead of binary catalysts (Starship test, Aug 14 unlock) to avoid replicating the Aug 10 supply-event failure.

Outcome

✗

Return

+9.65%

Status

scored

Maintain SPCX at ~$133.29 with Hold rating and execution-only discipline given the empirical track record of five of six prior losing decisions; cap position at 1-2% of portfolio given 7.8-8.2% ATR, trim 25-50% ahead of known supply events, and consider $115/$105 Sep put spreads on 25-30% of position for convexity through this week's binary CPI print. Upgrade to Overweight only on sustained close above $141.76 on >200M volume for 2 sessions; downgrade to Underweight only on close below $108 with >150M volume and RSI <40.

Outcome

✓

Return

-3.93%

Status

scored

Maintain SPCX at $138.74 under execution-only Hold framework — no directional call warranted given six consecutive losing directional attempts on this ticker. Two-tier execution: TRIM 50% only on confirmed technical failure at $140-142 (RSI divergence + declining volume + MACD rollover all required), or ADD on confirmed close above $141.97 with volume >1.5x average and RSI >55. Firm stop at $128 (Aug 5 basing low); structural failure at $108 with volume >150M and RSI <40 warrants full exit.

Outcome

✓

Return

+4.23%

Status

scored

SPCX is rated Hold at $133 with no directional call. Despite concerning fundamentals (72x forward P/E, negative TTM EPS, -41.6% operating margin, $9B FCF burn), five consecutive Underweight failures have triggered a structural regime signal requiring neutral execution-only language. The $140-142 resistance zone ($140-142 with 50 SMA + 200 SMA + upper Bollinger) has not been confirmed as a failure (requires RSI divergence + declining volume + MACD rollover + bearish engulfing), and the $101 lower Bollinger band has not been visited. A $115/$105 Sep put spread on 30-40% of the position is recommended for hedging through upcoming CPI, lockup tranche #2, and Q2 earnings. Re-engage bearish only on close below $108 with RSI <40, or bullish on close above $142 with volume >200M and RSI >55.

Outcome

✗

Return

+15.83%

Status

scored

Trim 30-40% of SPCX exposure at/near market ($114-115) into post-bounce strength, stage a second tranche into the $118-121 Bollinger midline zone, hold residual ~40-50% with closing-basis invalidation at $122-123 (not the trader's $125 intraday stop, which fails the ATR-compatibility test given $10.34 ATR), and layer a $95/$85 Sep put spread for convex downside protection through the Friday NFP binary catalyst and late-August NVIDIA earnings. Re-engagement requires two consecutive closes above $121.45 on above-average volume with RSI >50 holding, plus close above 50 SMA at $142.29, capped at half original size.